Positron emission tomography in patients with primary CNS lymphomas

Journal of Neuro-Oncology

Volumn 43, Issue 3, 1999, Pages 231-236

  Roelcke, U ^a,b   Leenders, K L ^a  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

Central nervous system; Lymphoma; Positron emission tomography

Indexed keywords

DEXAMETHASONE; FLUORODEOXYGLUCOSE F 18;

BIOCHEMISTRY; CENTRAL NERVOUS SYSTEM TUMOR; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOXIA; INFLAMMATION; LYMPHOMA; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PERFUSION; POSITRON EMISSION TOMOGRAPHY; REVIEW; STEREOTAXIC SURGERY; TOXOPLASMOSIS;

BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOMA, NON-HODGKIN; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032854418     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006202402010     Document Type: Review

References (31)

1. Herholz K, Wienhard K, Heiss WD: Validity of PET studies in brain tumors. Cereb Brain Metab Rev 2: 240-265, 1990
2. Di Chiro G: Positron emission tomography using [18F] fluoro-deoxyglucose in brain tumors: A powerful diagnostic and prognostic tool. Invest Radiol 22: 360-371, 1986
3. Roelcke U: PET: Brain tumor biochemistry. J Neuro-Oncol 22: 275-279, 1994
4. Wienhard K, Herholz K, Coenen HH, Rudolf J, Kling P, Stöcklin G, Heiss WD: Increased amino acid transport into brain tumors measured by PET of L-(2-18F)Fluorotyrosine. J Nucl Med 32: 1338-1346, 1991
5. Leenders KL: PET: Blood flow and oxygen consumption. J Neuro-Oncol 22: 261-268, 1994
6. Kuwabara Y, Ichiya Y, Otsuka M, Miyake Y, Gunasekera R, Hasuo K, Masuda K, Takeshita I, Fukui H: High [18F]FDG uptake in primary cerebral lymphoma: a PET study. J Comput Assist Tomogr 12: 47-48, 1988
7. Ott RJ, Brada M, Flower MA, Babich JW, Cherry SR, Deehan BJ: Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer 27: 1356-1361, 1991
8. Sawataishi J, Mineura K, Sasajima T, Kowada M, Sugawara A, Shishido F: Effects of radiotherapy determined by 11C-methyl-L-methionine positron emission tomography in patients with primary cerebral malignant lymphoma. Neuroradiology 34: 517-519, 1992
9. Rosenfeld SS, Hoffman JM, Coleman RE, Glantz MJ, Hanson MW, Schold SC: Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography. J Nucl Med 33: 532-536, 1992
10. Griffeth LK, Rich KM, Dehdashti F, Simpson JR, Fusselman MJ, McGuire AH, Siegel BA: Brain metastases from non-central nervous system tumors: evaluation with PET. Radiology 186: 37-44, 1993
11. Ogawa T, Kanno I, Hatazawa J, Inugami A, Fujita H, Shimosegawa E, Murakami M, Okudera T, Uemura K, Yasui N: Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain. Radiographics 14: 101-110, 1994
12. Pruim J, Willemsen AT, Molenaar WM, van Waarde A, Paans AM, Heesters MA, Go KG, Visser GM, Franssen EJ, Vaalburg W: Brain tumors: L-[1-C-11]tyrosine PET for visualization and quantification of protein synthesis rate. Radiology 197: 221-226, 1995
13. Hoffman JM, Waskin HA, Schifter T, Hanson MW, Gray L, Rosenfeld S, Coleman RE: FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 34: 567-575, 1993
14. Pierce MA, Johnson MD, Maciunas RJ, Murray MJ, Allen GS, Harbison MA, Creasy JL, Kessler RM. Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med 123: 594-598, 1995
15. Heald AE, Hoffman JM, Bartlett JA, Waskin HA: Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET). Int J STD AIDS 7: 337-346, 1996
16. Bergström M, Collins VP, Ehrin E, Ericson K, Eriksson L, Greitz T, Halldin C, von Holst H, Langström B, Liljia A, Lundquist H, Nagren K: Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga] EDTA, [11C] glucose, and [11C] methionine. J Comput Ass Tomogr 7: 1062-1066, 1983
17. Herholz K, Pietrzyk U, Voges J, Schröder R, Halber M, Treuer H, Sturm V, Heiss WD: Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study. J Neurosurg 79: 853-858, 1993
18. Osborn AG: Diagnostic Neuroradiology. Mosby, St. Louis, 1994, pp 620-623
19. Mosskin M, van Holst H, Bergstroem M, Collins VP, Eriksson L, Johnstroem P, Noren G: Positron emission tomography with 11C methionine and computed tomography of intracranial tumors compared with histopathological examination of multiple biopsies. Acta Radiol 28: 673-681, 1987
20. Pirotte B, Goldman S, Bidaut LM, Luxen A, Stanus E, Brucher JM, Baleriaux D, Brotchi J, Levivier M: Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy. Acta Neurochir Wien 134: 79-82, 1995
21. Herholz K, Thiel A, Wienhard K, Pietrzyk U, von Stockhausen HM, Karbe H, Kessler J, Bruckbauer T, Halber M, Heiss WD: Individual functional anatomy of verb generation. Neuroimage 3: 185-194, 1996
22. Herholz K, Thiel A, von Stockhausen HM, Halber M, Weber-Luxemburger G, van Leyen-Pilgram K, Pietrzyk U, Heiss WD: Speech activation studies in glioma patients (Abstract). J Neuro-Oncol 30: 113, 1996
23. Meyer JS, Marchosky JA, Hickey WF: Cell kinetic classification of tumors of the nervous system by DNA precursor labeling in vitro. Hum Pathol 24: 1357-1364, 1993
24. Hochberg FH, Miller DC: Primary central nervous system lymphoma. J Neurosurg 68: 835-853, 1988
25. Tjuvajev J, Muraki A, Ginos J, Berk J, Koutcher J, Ballon D, Beattie B, Finn R, Blasberg R: Iododeoxyuridine uptake and retention as a measure of tumor growth. J Nucl Med 34: 1152-1162, 1993
26. Blasberg RG, Roelcke U, Weinreich R, von Ammon K, Crompton N, Günther I, Knust E, Beattie B, Finn R, Leenders KL: [124I]-iododeoxyuridine imaging tumors proliferation (Abstract). J Nucl Med 37: 53P, 1996
27. Glantz MJ, Hoffman JM, Coleman RE, Friedmann AH, Hanson MW, Burger PC, Herndon JE, Meisler WJ, Schold SC: Identification of early recurrence of primary central nervous system tumors by [18F] fluorodeoxyglucose positron emission tomography. Ann Neurol 29: 347-355, 1991
28. Vaupel P: Blood flow and metabolic microenvironment of brain tumors. J Neuro-Oncol 22: 261-268, 1994
29. Valk PE, Mathis CA, Prados MD, Gilbert JC, Budinger TF: Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoro-misonidazole. J Nucl Med 33: 2133-2137, 1992
30. Tjuvajev JG, Stockhammer G, Desai R, Uehara H, Watanabe K, Gansbacher B, Blasberg RG: Imaging the expression of transfected genes in vivo. Cancer Res 55: 6126-6132, 1995
31. Tjuvajev JG, Finn R, Watanabe K, Joshi R, Oku T, Kennedy J, Beattie B, Koutcher J, Larson S, Blasberg RG: Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res 56: 4087-4095, 1996